You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ethanol-containing docetaxel

Showing 1 - 25 of 7,499
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Docetaxel Ethanol-induced Symptoms; The Incidence and Risk

Completed
  • Breast Cancer
  • +6 more
    • Guri-si, Korea, Republic of
      Hanyang University Guri Hospital
    Jul 26, 2022

    Locally Advanced or Metastatic NSCLC Trial (Utidelone Injection, Docetaxel Injection)

    Not yet recruiting
    • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    • Utidelone Injection
    • Docetaxel Injection
    • (no location specified)
    Dec 30, 2022

    Non-small Cell Lung Adenocarcinoma, Squamous Cell Carcinoma of Lung Trial in Guangzhou (SI-B001, Docetaxel)

    Not yet recruiting
    • Non-small Cell Lung Adenocarcinoma
    • Squamous Cell Carcinoma of Lung
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jul 5, 2023

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Solid Tumor Trial in Orland Park, Seattle (Nozin, Best Practice)

    Suspended
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +2 more
    • Orland Park, Illinois
    • +1 more
    Sep 20, 2022

    HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/

    Not yet recruiting
    • HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
    • SHR-A1811
    • Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
    • (no location specified)
    Nov 6, 2023

    Breast Cancer Trial in Oslo (Docetaxel)

    Completed
    • Breast Cancer
    • Oslo, Norway
      RRHF
    Apr 21, 2022

    Nonsquamous NSCLC Trial in Yichang (Sintilimab, Docetaxel, Pemetrexed)

    Recruiting
    • Nonsquamous Non-Small Cell Lung Cancer
    • Yichang, Hubei, China
      Department of Medical Oncology, Central Hospital of Yichang City
    Nov 5, 2021

    NSCLC Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Docetaxel)

    Completed
    • Carcinoma, Non-Small-Cell Lung
    • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
    • Docetaxel
    • Beijing, China
    • +37 more
    Jan 9, 2023

    Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

    Not yet recruiting
    • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
    • Guangzhou, Guangdong, China
      Sun Yat-sen University
    Oct 24, 2023

    Breast Cancer Trial (Nanoxel M, Taxotere, Doxorubicin)

    Not yet recruiting
    • Breast Cancer
    • Nanoxel M
    • +3 more
    • (no location specified)
    Jan 20, 2022

    Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Locally Advanced Operable
    • Guangzhou, Guangdong, China
    • +1 more
    Sep 4, 2023

    Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)

    Completed
    Has Results
    • Bladder Cancer
    • Urothelial Carcinoma
    • Birmingham, Alabama
    • +34 more
    Jul 7, 2022

    Nonsquamous NSCLC Trial in Yichang (Sintilimab, Docetaxel, Pemetrexed)

    Recruiting
    • Nonsquamous Non-Small Cell Lung Cancer
    • Yichang, Hubei, China
      Department of Medical Oncology, Central Hospital of Yichang City
    Nov 5, 2021

    Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal

    Recruiting
    • Cervical Esophagus Adenocarcinoma
    • +12 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    Stress, Physiological, Ethanol Intoxication, Distress, Emotional Trial in Lubbock (Relevant Trier Social Stressor Test (TSST),

    Not yet recruiting
    • Stress, Physiological
    • +2 more
    • Relevant Trier Social Stressor Test (TSST)
    • +4 more
    • Lubbock, Texas
      Texas Tech University
    Oct 19, 2023

    Breast Cancer Trial in Los Angeles (trastuzumab, carboplatin, docetaxel)

    Completed
    • Breast Cancer
    • trastuzumab
    • +4 more
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center, UCLA
    Jul 30, 2020

    Metastatic Prostate Cancer Trial in Montréal (Cabazitaxel plus prednisone, Docetaxel plus prednisone)

    Recruiting
    • Metastatic Prostate Cancer
    • Cabazitaxel plus prednisone
    • Docetaxel plus prednisone
    • Montréal, Quebec, Canada
      Centre Hospitalier de l'Université de Montréal
    Aug 9, 2021

    Electronic Cigarette Use Trial in Richmond (E-cigarette liquid with ethanol, 1 puff, E-cigarette liquid without ethanol, 1 puff,

    Completed
    • Electronic Cigarette Use
    • E-cigarette liquid with ethanol, 1 puff
    • +3 more
    • Richmond, Virginia
      Virginia Commonwealth University
    Apr 11, 2022

    NSCLC Trial in Changsha (Sintilimab Combined With Docetaxel)

    Completed
    • Non-small Cell Lung Cancer
    • Sintilimab Combined With Docetaxel
    • Changsha, Hunan, China
      Hunan Provincal Tumor Hospital
    Mar 1, 2022

    Carcinoma, NSCLC Trial in Worldwide (nivolumab, ipilimumab, cabozantinib)

    Withdrawn
    • Carcinoma, Non-small Cell Lung Cancer
    • nivolumab
    • +5 more
    • Detroit, Michigan
    • +22 more
    Mar 8, 2022

    NSCLC Trial in Australia, China, United States (Docetaxel + Plinabulin (DP), Docetaxel (D))

    Completed
    • Non-Small Cell Lung Cancer
    • Docetaxel + Plinabulin (DP)
    • Docetaxel (D)
    • Chandler, Arizona
    • +56 more
    Sep 9, 2022

    NSCLC Trial in Worldwide (Tislelizumab, Docetaxel)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Salvador, Bahia, Brazil
    • +85 more
    Jun 23, 2022

    Metastatic Castration-resistant Prostate Cancer Trial in Bellinzona, Chur, St. Gallen (Docetaxel micellar)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Docetaxel micellar
    • Bellinzona, Switzerland
    • +2 more
    Nov 7, 2022

    Squamous-Cell Non-Small-Cell Lung Cancer Trial in Worldwide (Bemarituzumab, Docetaxel)

    Recruiting
    • Squamous-Cell Non-Small-Cell Lung Cancer
    • Orange, California
    • +24 more
    Jul 27, 2022

    Healthy Trial in Basel (Lysergic Acid Diethylamide Base oral drinking solution, Lysergic Acid Diethylamide Base solid

    Recruiting
    • Healthy
    • Lysergic Acid Diethylamide Base oral drinking solution
    • +4 more
    • Basel, Switzerland
      Clinical Pharmacology & Toxicology, University Hospital Basel
    Mar 30, 2022